| 2024-08 |
A self-powered and supercapacitive microneedle continuous glucose monitoring system with a wide range of glucose detection capabilities |
Biosensors and Bioelectronics
|
| 2024-03 |
Mortality in metabolic dysfunction-associated steatotic liver disease: A nationwide population-based cohort study |
Metabolism: Clinical and Experimental
|
| 2024-01 |
Intact ketogenesis predicted reduced risk of moderate-severe metabolic-associated fatty liver disease assessed by liver transient elastography in newly diagnosed type 2 diabetes |
Frontiers in Endocrinology
|
| 2023-12 |
SGLT2 and DPP4 inhibitors improve Alzheimer's disease–like pathology and cognitive function through distinct mechanisms in a T2D–AD mouse model |
Biomedicine and Pharmacotherapy
|
| 2023-10 |
Lean or non-obese nonalcoholic fatty liver disease patients: Are they really lean? |
Clinical and Molecular Hepatology
|
| 2023-09 |
MAFLD might be better in identifying subjects with sarcopenia or cardiovascular risk than NAFLD: A nationwide study |
Journal of Gastroenterology and Hepatology
|
| 2023-08 |
SARS-CoV-2 protein ORF8 limits expression levels of Spike antigen and facilitates immune evasion of infected host cells |
Journal of Biological Chemistry
|
| 2023-08 |
Comparisons of the prediction models for undiagnosed diabetes between machine learning versus traditional statistical methods |
Scientific Reports
|
| 2023-08 |
Mitochondria-derived peptide SHLP2 regulates energy homeostasis through the activation of hypothalamic neurons |
Nature Communications
|
| 2023-08 |
Increased expression of sodium-glucose cotransporter 2 and O-GlcNAcylation in hepatocytes drives non-alcoholic steatohepatitis |
Metabolism: Clinical and Experimental
|
| 2023-07 |
Ablation of the deubiquitinase USP15 ameliorates nonalcoholic fatty liver disease and nonalcoholic steatohepatitis |
Experimental & Molecular Medicine
|
| 2023-07 |
β-hydroxybutyrate as a biomarker of β-cell function in new-onset type 2 diabetes and its association with treatment response at 6 months: Type 2 diabetes and β-hydroxybutyrate level |
Diabetes and Metabolism
|
| 2023-06 |
O-GlcNAcylation of RIPK1 rescues red blood cells from necroptosis |
Frontiers in Immunology
|
| 2023-05 |
Tcf7l2 in hepatocytes regulates de novo lipogenesis in diet-induced non-alcoholic fatty liver disease in mice |
Diabetologia
|
| 2023-05 |
Anagliptin twice-daily regimen improves glycaemic variability in subjects with type 2 diabetes: A double-blind, randomized controlled trial |
Diabetes, Obesity and Metabolism
|
| 2023-03 |
Non-Alcoholic Fatty Liver Disease with Sarcopenia and Carotid Plaque Progression Risk in Patients with Type 2 Diabetes Mellitus |
Diabetes and Metabolism Journal
|
| 2023-03 |
Moderate-intensity statin with ezetimibe vs. high-intensity statin in patients with diabetes and atherosclerotic cardiovascular disease in the RACING trial |
European Heart Journal
|
| 2023-03 |
Metabolic dysfunction associated fatty liver disease identifies subjects with cardiovascular risk better than non-alcoholic fatty liver disease |
Liver International
|
| 2023-02 |
Impaired ketogenesis is associated with metabolic-associated fatty liver disease in subjects with type 2 diabetes |
FRONTIERS IN ENDOCRINOLOGY
|
| 2023-01 |
Fatty Liver & Diabetes Statistics in Korea: Nationwide Data 2009 to 2017 |
Diabetes & metabolism journal
|
| 2023-01 |
Prognostic value of resting heart rate in predicting undiagnosed diabetes in adults: Korean National Health and Nutrition Examination Survey 2008–2018 |
Nutrition, Metabolism and Cardiovascular Diseases
|
| 2022-09 |
Adherence to healthy lifestyle behaviors as a preventable risk factor for severe hypoglycemia in people with type 2 diabetes: A longitudinal nationwide cohort study |
Journal of Diabetes Investigation
|
| 2022-09 |
Editorial: Pharmacology and treatment methods for NAFLD in the context of diabetes |
Frontiers in Endocrinology
|
| 2022-09 |
Dapagliflozin attenuates diabetes-induced diastolic dysfunction and cardiac fibrosis by regulating SGK1 signaling. |
BMC Medicine
|
| 2022-08 |
Protective Effect of Delta-Like 1 Homolog Against Muscular Atrophy in a Mouse Model |
ENDOCRINOLOGY AND METABOLISM
|
| 2022-08 |
Effects of a Phosphodiesterase inhibitor on the Browning of Adipose Tissue in Mice |
Biomedicines
|
| 2022-08 |
The effects of the voglibose on non-alcoholic fatty liver disease in mice model |
SCIENTIFIC REPORTS
|
| 2022-07 |
Advanced Liver Fibrosis Is Associated with Chronic Kidney Disease in Patients with Type 2 Diabetes Mellitus and Nonalcoholic Fatty Liver Disease |
Diabetes and Metabolism Journal
|
| 2022-06 |
Differences in complication patterns in subgroups of type 2 diabetes according to insulin resistance and beta-cell function |
Scientific Reports
|
| 2022-06 |
A GLP-1/GLP-2 receptor dual agonist to treat NASH: Targeting the gut-liver axis and microbiome |
HEPATOLOGY
|
| 2022-06 |
Sodium Glucose Cotransporter-2 Inhibitors as an Add-on Therapy to Metformin Plus Dipeptidyl Peptidase-4 Inhibitor in Patients with Type 2 Diabetes |
YONSEI MEDICAL JOURNAL
|
| 2022-05 |
Association of Metabolomic Change and Treatment Response in Patients with Non-Alcoholic Fatty Liver Disease |
Biomedicines
|
| 2022-05 |
The predictive value of resting heart rate in identifying undiagnosed diabetes in Korean adults: Korea National Health and Nutrition Examination Survey |
Epidemiology and Health
|
| 2022-04 |
Inhibition of CXXC5 function reverses obesity-related metabolic diseases |
Clinical and Translational Medicine
|
| 2022-04 |
Ideal cardiovascular health duration and risk of chronic kidney disease and cardiovascular disease |
HEART
|
| 2022-04 |
Short Term Isocaloric Ketogenic Diet Modulates NLRP3 Inflammasome Via B-hydroxybutyrate and Fibroblast Growth Factor 21 |
FRONTIERS IN IMMUNOLOGY
|
| 2022-04 |
Severe Hypoglycemia Increases Dementia Risk and Related Mortality: A Nationwide, Population-based Cohort Study |
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM
|
| 2022-03 |
Performance of Diabetes and Kidney Disease Screening Scores in Contemporary United States and Korean Populations |
Diabetes and Metabolism Journal
|
| 2022-03 |
Fibrotic Burden Determines Cardiovascular Risk among Subjects with Metabolic Dysfunction-Associated Fatty Liver Disease |
Gut and Liver
|
| 2022-03 |
Cardiovascular Risk Is Elevated in Lean Subjects with Nonalcoholic Fatty Liver Disease |
GUT AND LIVER
|
| 2022-03 |
Ezetimibe combination therapy with statin for non-alcoholic fatty liver disease: an open-label randomized controlled trial (ESSENTIAL study) |
BMC MEDICINE
|
| 2022-02 |
State-of-the-Art Overview of the Pharmacological Treatment of Non-Alcoholic Steatohepatitis |
Endocrinology and Metabolism
|
| 2022-02 |
Analysis of Severe Hypoglycemia Among Adults With Type 2 Diabetes and Nonalcoholic Fatty Liver Disease |
Jama Network Open
|
| 2022-01 |
Renal Tubular Damage Marker, Urinary N-acetyl-β-D-Glucosaminidase, as a Predictive Marker of Hepatic Fibrosis in Type 2 Diabetes Mellitus |
Diabetes and Metabolism Journal
|
| 2022-01 |
Blood Pressure Levels and Risks of Dementia: a Nationwide Study of 4.5 Million People |
HYPERTENSION
|
| 2022-01 |
Real-world evidence on the strategy of olmesartan-based triple single-pill combination in Korean hypertensive patients: a prospective, multicenter, observational study (RESOLVE-PRO) |
Clincal Hypertension
|
| 2021-12 |
The Leg Fat to Total Fat Ratio Is Associated with Lower Risks of Non-Alcoholic Fatty Liver Disease and Less Severe Hepatic Fibrosis: Results from Nationwide Surveys (KNHANES 2008–2011) |
Endocrinology and Metabolism
|
| 2021-12 |
Uric Acid Variability as a Predictive Marker of Newly Developed Cardiovascular Events in Type 2 Diabetes |
Frontiers in Cardiovascular Medicine
|
| 2021-11 |
Proteinuria as a significant predictive factor for the progression of carotid artery atherosclerosis in non-albuminuric type 2 diabetes |
DIABETES RESEARCH AND CLINICAL PRACTICE
|
| 2021-11 |
Ipragliflozin, an SGLT2 Inhibitor, Ameliorates High-Fat Diet-Induced Metabolic Changes by Upregulating Energy Expenditure through Activation of the AMPK/ SIRT1 Pathway |
Diabetes and Metabolism Journal
|
| 2021-10 |
Association of circulating metabolites with incident type 2 diabetes in an obese population from a national cohort |
DIABETES RESEARCH AND CLINICAL PRACTICE
|
| 2021-10 |
Metabolic Dysfunction-Associated Fatty Liver Disease and Incident Cardiovascular Disease Risk: A Nationwide Cohort Study |
CLINICAL GASTROENTEROLOGY AND HEPATOLOGY
|
| 2021-09 |
Body Weight Variability: A Marker for Increased Risk or a Causative Factor for Dementia? |
Journal of Obesity & Metabolic Syndrome
|
| 2021-08 |
Role of DPP-4 and SGLT2 Inhibitors Connected to Alzheimer’s Disease in Type 2 Diabetes Mellitus. |
FRONTIERS IN NEUROSCIENCE
|
| 2021-08 |
Non-Laboratory-Based Simple Screening Model for Nonalcoholic Fatty Liver Disease in Patients with Type 2 Diabetes Developed Using Multi-Center Cohorts |
Endocrinology and Metabolism
|
| 2021-06 |
Association between the severity of liver fibrosis and cardiovascular outcomes in patients with type 2 diabetes |
JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY
|
| 2021-05 |
Risks and Prognoses of Alzheimer's Disease and Vascular Dementia in Patients With Insomnia: A Nationwide Population-Based Study |
FRONTIERS IN NEUROLOGY
|
| 2021-04 |
Nonalcoholic fatty liver disease, diastolic dysfunction, and impaired myocardial glucose uptake in patients with type 2 diabetes |
DIABETES OBESITY & METABOLISM
|
| 2021-02 |
Guidelines for the use and interpretation of assays for monitoring autophagy (4th edition) |
AUTOPHAGY
|
| 2021-02 |
Glycaemic control with add-on thiazolidinedione or a sodium-glucose co-transporter-2 inhibitor in patients with type 2 diabetes after the failure of an oral triple antidiabetic regimen: A 24-week, randomized controlled trial |
DIABETES OBESITY & METABOLISM
|
| 2021-02 |
O-Linked N-Acetylglucosamine Modification of Mitochondrial Antiviral Signaling Protein Regulates Antiviral Signaling by Modulating Its Activity |
FRONTIERS IN IMMUNOLOGY
|
| 2020-11 |
Metformin and Gastrointestinal Cancer Development in Newly Diagnosed Type 2 Diabetes: A Population-Based Study in Korea |
Clinical and Translational Gastroenterology
|
| 2020-11 |
Effect of Switching from Linagliptin to Teneligliptin Dipeptidyl Peptidase-4 Inhibitors in Older Patients with Type 2 Diabetes Mellitus |
Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy
|
| 2020-11 |
SQSTM1/p62 activates NFE2L2/NRF2 via ULK1-mediated autophagic KEAP1 degradation and protects mouse liver from lipotoxicity |
AUTOPHAGY
|
| 2020-11 |
Association between liver fibrosis and appendicular skeletal muscle mass during antiviral therapy in chronic hepatitis B |
DIGESTIVE AND LIVER DISEASE
|
| 2020-10 |
Dipeptidyl peptidase-4 inhibitor protects against non-alcoholic steatohepatitis in mice by targeting TRAIL receptor-mediated lipoapoptosis via modulating hepatic dipeptidyl peptidase-4 expression |
SCIENTIFIC REPORTS
|
| 2020-10 |
Pharmaceutical efficacy of gypenoside lxxv on non‐alcoholic steatohepatitis (Nash) |
Biomolecules
|
| 2020-10 |
Sarcopenia is associated with non-alcoholic fatty liver disease in men with type 2 diabetes |
DIABETES & METABOLISM
|
| 2020-09 |
Mechanisms of sodium–glucose cotransporter 2 inhibition: Insights from large-scale proteomics |
DIABETES CARE
|
| 2020-08 |
Hepatic fibrosis is associated with total proteinuria in Korean patients with type 2 diabetes |
MEDICINE
|
| 2020-07 |
Low muscle mass is associated with carotid atherosclerosis in patients with type 2 diabetes |
ATHEROSCLEROSIS
|
| 2020-07 |
Glucose loading enhances the value of 18F-FDG PET/CT for the characterization and delineation of cerebral gliomas |
Cancers
|
| 2020-06 |
O-GlcNAcylation on LATS2 disrupts the Hippo pathway by inhibiting its activity |
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
|
| 2020-06 |
Non-Alcoholic Fatty Liver Disease in Patients with Type 2 Diabetes Mellitus: A Position Statement of the Fatty Liver Research Group of the Korean Diabetes Association |
Diabetes and Metabolism Journal
|
| 2020-06 |
Nonalcoholic steatohepatitis and progression of carotid atherosclerosis in patients with type 2 diabetes a Korean cohort study |
CARDIOVASCULAR DIABETOLOGY
|
| 2020-05 |
Anti-Inflammatory Effect for Atherosclerosis Progression by Sodium-Glucose Cotransporter 2 (SGLT-2) Inhibitor in a Normoglycemic Rabbit Model |
KOREAN CIRCULATION JOURNAL
|
| 2020-05 |
SGLT2 inhibition modulates NLRP3 inflammasome activity via ketones and insulin in diabetes with cardiovascular disease |
NATURE COMMUNICATIONS
|
| 2020-04 |
Gamma glutamyltransferase and risk of dementia in prediabetes and diabetes |
SCIENTIFIC REPORTS
|
| 2020-04 |
Association between Non-Alcoholic Steatohepatitis and Left Ventricular Diastolic Dysfunction in Type 2 Diabetes Mellitus |
Diabetes and Metabolism Journal
|
| 2020-04 |
Nonalcoholic Fatty Liver Disease and Sarcopenia Are Independently Associated With Cardiovascular Risk |
AMERICAN JOURNAL OF GASTROENTEROLOGY
|
| 2020-03 |
Comparison of Renal Effects of Ezetimibe-Statin Combination versus Statin Monotherapy: A Propensity-Score-Matched Analysis |
Journal of Clinical Medicine
|
| 2020-02 |
Efficacy and Safety of Omega-3 Fatty Acids in Patients Treated with Statins for Residual Hypertriglyceridemia: A Randomized, Double-Blind, Placebo-Controlled Clinical Trial |
Diabetes and Metabolism Journal
|
| 2020-01 |
Ipragliflozin Additively Ameliorates Non-Alcoholic Fatty Liver Disease in Patients with Type 2 DiabetesControlled with Metformin and Pioglitazone: A 24-Week Randomized Controlled Trial |
Journal of Clinical Medicine
|
| 2020-01 |
Sarcopenia: an emerging risk factor for non-alcoholic fatty liver disease |
HEPATOLOGY INTERNATIONAL
|
| 2020-01 |
Association Between Serum Bilirubin and the Progression of Carotid Atherosclerosis in Type 2 Diabetes |
Journal of Lipid and Atherosclerosis
|
| 2020-01 |
Proteinuria is Associated with Carotid Artery Atherosclerosis in Non-Albuminuric Type 2 Diabetes: A Cross-Sectional Study |
Journal of Clinical Medicine
|
| 2019-12 |
Efficacy and Safety of Gemigliptin in Post-Transplant Patients With Type 2 Diabetes Mellitus |
TRANSPLANTATION PROCEEDINGS
|
| 2019-10 |
The Effectiveness of Intermittent Fasting to Reduce Body Mass Index and Glucose Metabolism: A Systematic Review and Meta-Analysis |
Journal of Clinical Medicine
|
| 2019-09 |
β-cell autophagy: Mechanism and role in β-cell dysfunction |
MOLECULAR METABOLISM
|
| 2019-09 |
Current Management of Type 2 Diabetes Mellitus in Primary Care Clinics in Korea |
Endocrinology and Metabolism
|
| 2019-08 |
Glucometabolic characteristics and higher vascular complication risk in Korean patients with type 2 diabetes with non-albumin proteinuria |
JOURNAL OF DIABETES AND ITS COMPLICATIONS
|
| 2019-08 |
Predictive factors for the development of diabetes in cancer patients treated with phosphatidylinositol 3-kinase inhibitors |
CANCER CHEMOTHERAPY AND PHARMACOLOGY
|